A prior infection offers protection in the range of 80%, compared to about 95% for the Moderna and Pfizer vaccines, said Dr. John Wherry, director of the Institute for Immunology at the Perelman School of Medicine at the University of Pennsylvania. That means about 15 to 20 out of every 100 people who have previously had COVID-19 could get reinfected, while 5 out of every 100 people who got an mRNA vaccine might get infected.
It is not clear to me why a prior infection wouldn't be more effective at preventing the disease.
No comments:
Post a Comment